Patents by Inventor Hakan Mellstedt

Hakan Mellstedt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
    Patent number: 11660303
    Abstract: A compound of formula (I?) or (I?) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.
    Type: Grant
    Filed: April 30, 2021
    Date of Patent: May 30, 2023
    Assignee: KANCERA AB
    Inventors: Håkan Mellstedt, Styrbjörn Byström, Jan Vågberg, Elisabeth Olsson
  • 2-PHENYLIMIDAZO[4,5-B]PYRIDIN-7-AMINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY
    Publication number: 20210267994
    Abstract: A compound of formula (I?) or (I?) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.
    Type: Application
    Filed: April 30, 2021
    Publication date: September 2, 2021
    Inventors: Håkan MELLSTEDT, Styrbjörn BYSTRÖM, Jan VÅGBERG, Elisabeth OLSSON
  • 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
    Patent number: 11008318
    Abstract: Compound of formula (I?) or (I?) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: May 18, 2021
    Assignee: KANCERA AB
    Inventors: Håkan Mellstedt, Styrbjörn Byström, Jan Vågberg, Elisabeth Olsson
  • 2-phenyl-3H-imidazo[4,5-B]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
    Patent number: 10550113
    Abstract: A compound of formula (I?) or (I?) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: February 4, 2020
    Assignee: KANCERA AB
    Inventors: Hakan Mellstedt, Styrbjorn Bystrom, Jan Vagberg, Elisabeth Olsson
  • 2-PHENYLIMIDAZO[4,5-B]PYRIDIN-7-AMINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY
    Publication number: 20200024272
    Abstract: Compound of formula (I?) or (I?) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.
    Type: Application
    Filed: July 10, 2017
    Publication date: January 23, 2020
    Inventors: Håkan MELLSTEDT, Styrbjörn BYSTRÖM, Jan VÅGBERG, Elisabeth OLSSON
  • 2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY
    Publication number: 20180002329
    Abstract: A compound of formula (I?) or (I?) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.
    Type: Application
    Filed: February 1, 2016
    Publication date: January 4, 2018
    Inventors: Hakan MELLSTEDT, Styrbjorn BYSTROM, Jan VAGBERG, Elisabeth OLSSON
  • Biological inhibitors of ROR1 capable of inducing cell death
    Patent number: 9150647
    Abstract: The invention relates to antibodies and siRNA molecules for inducing cell death by the specific binding of ROR1, domains thereof of nucleotide molecules encoding ROR1. There are also provided methods involving and uses of the antibodies and siRNA molecules of the invention.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: October 6, 2015
    Assignee: Kancera AB
    Inventors: Hakan Mellstedt, Ingrid Teige
  • BIOLOGICAL INHIBITORS OF ROR1 CAPABLE OF INDUCING CELL DEATH
    Publication number: 20140004156
    Abstract: The invention relates to antibodies and siRNA molecules for inducing cell death by the specific binding of ROR1, domains thereof of nucleotide molecules encoding ROR1. There are also provided methods involving and uses of the antibodies and siRNA molecules of the invention.
    Type: Application
    Filed: December 10, 2010
    Publication date: January 2, 2014
    Inventors: Hakan Mellstedt, Hodjattallah Rabbani, Ingrid Teige